JOSEPH KLEIN III - 17 Jan 2023 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
Director
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Joseph Klein III
Issuer symbol
IONS
Transactions as of
17 Jan 2023
Transactions value $
-$80,000
Form type
4
Filing time
18 Jan 2023, 19:19:09 UTC
Previous filing
19 Jul 2022
Next filing
06 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Sale -$80K -2K -10.64% $40.00 16.8K 17 Jan 2023 Direct F1
holding IONS Common Stock 100 17 Jan 2023 by Son F2
holding IONS Common Stock 6K 17 Jan 2023 by Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 17, 2022
F2 The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.